Kathleen M. Grima

612 total citations
16 papers, 448 citations indexed

About

Kathleen M. Grima is a scholar working on Genetics, Hematology and Immunology. According to data from OpenAlex, Kathleen M. Grima has authored 16 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 6 papers in Hematology and 5 papers in Immunology. Recurrent topics in Kathleen M. Grima's work include Hemoglobinopathies and Related Disorders (6 papers), Complement system in diseases (4 papers) and Blood transfusion and management (4 papers). Kathleen M. Grima is often cited by papers focused on Hemoglobinopathies and Related Disorders (6 papers), Complement system in diseases (4 papers) and Blood transfusion and management (4 papers). Kathleen M. Grima collaborates with scholars based in United States and Malaysia. Kathleen M. Grima's co-authors include Christopher D. Hillyer, Cassandra D. Josephson, Marta‐Inés Castillejo, Beth H. Shaz, Jeffrey L. Winters, Bruce C. McLeod, Joan C. Pehta, Janice M. Nelson, Raissa Lerner and Alvaro A. Pineda and has published in prestigious journals such as Blood, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Kathleen M. Grima

15 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathleen M. Grima United States	12	176	125	100	87	69	16	448
G. Stiegler Austria	12	240 1.4×	80 0.6×	97 1.0×	59 0.7×	60 0.9×	29	486
SJ Slichter United States	9	453 2.6×	198 1.6×	103 1.0×	58 0.7×	77 1.1×	16	664
Karim Boudjedir France	8	257 1.5×	72 0.6×	55 0.6×	41 0.5×	210 3.0×	23	505
N. L. C. Luban United States	14	362 2.1×	188 1.5×	52 0.5×	55 0.6×	146 2.1×	23	619
Jeong Won Shin South Korea	11	156 0.9×	48 0.4×	44 0.4×	32 0.4×	51 0.7×	39	419
A. Insunza Spain	9	163 0.9×	54 0.4×	44 0.4×	23 0.3×	75 1.1×	24	366
Juan Montoro Spain	17	363 2.1×	60 0.5×	88 0.9×	34 0.4×	48 0.7×	74	688
Theodora Foukaneli United Kingdom	8	474 2.7×	63 0.5×	142 1.4×	18 0.2×	143 2.1×	12	634
R. Kekomäki Finland	12	260 1.5×	89 0.7×	56 0.6×	33 0.4×	19 0.3×	21	439
W. Q. Ascari United States	8	286 1.6×	95 0.8×	47 0.5×	22 0.3×	90 1.3×	12	497

Countries citing papers authored by Kathleen M. Grima

Since Specialization

Citations

This map shows the geographic impact of Kathleen M. Grima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen M. Grima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen M. Grima more than expected).

Fields of papers citing papers by Kathleen M. Grima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen M. Grima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen M. Grima. The network helps show where Kathleen M. Grima may publish in the future.

Co-authorship network of co-authors of Kathleen M. Grima

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen M. Grima. A scholar is included among the top collaborators of Kathleen M. Grima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen M. Grima. Kathleen M. Grima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Kessler, Debra, Kathleen M. Grima, Jay E. Valinsky, et al.. (2013). The integration of high-throughput testing of blood donors for cardiovascular disease risk assessment and prevention. Transfusion and Apheresis Science. 49(2). 263–267. 4 indexed citations

Kessler, Debra, Kathleen M. Grima, David Vlahov, et al.. (2012). Cardiovascular disease risk assessment and prevention in blood donors. Transfusion. 52(10). 2174–2182. 9 indexed citations

Grima, Kathleen M., et al.. (2012). Seroprevalence of Chagas Infection in the Donor Population. PLoS neglected tropical diseases. 6(7). e1771–e1771. 11 indexed citations

Shaz, Beth H., Kathleen M. Grima, & Christopher D. Hillyer. (2011). 2‐(Diethylhexyl)phthalate in blood bags: is this a public health issue?. Transfusion. 51(11). 2510–2517. 30 indexed citations

Josephson, Cassandra D., Marta‐Inés Castillejo, Kathleen M. Grima, & Christopher D. Hillyer. (2010). ABO-mismatched platelet transfusions: Strategies to mitigate patient exposure to naturally occurring hemolytic antibodies. Transfusion and Apheresis Science. 42(1). 83–88. 89 indexed citations

Tschernia, A., Neal S. LeLeiko, Kathleen M. Grima, et al.. (2002). Anti-HLA antibody removal by extracorporeal immunoadsorption in two hyperimmunized pediatric patients awaiting hepatointestinal transplantation. Transplantation Proceedings. 34(3). 900–901. 2 indexed citations

Grima, Kathleen M., et al.. (2002). Exchange transfusion for malaria and babesia infection. Transfusion Medicine Reviews. 16(3). 239–250. 49 indexed citations

Winters, Jeffrey L., Alvaro A. Pineda, Bruce C. McLeod, & Kathleen M. Grima. (2000). Therapeutic apheresis in renal and metabolic diseases. Journal of Clinical Apheresis. 15(1-2). 53–73. 35 indexed citations

Lerner, Raissa, et al.. (2000). Evaluation of Solvent/Detergent-Treated Plasma in Patients with a Prolonged Prothrombin Time. Vox Sanguinis. 79(3). 161–167. 34 indexed citations

10.

Grima, Kathleen M.. (2000). Therapeutic apheresis in hematological and oncological diseases. Journal of Clinical Apheresis. 15(1‐2). 28–28.

11.

Grima, Kathleen M.. (2000). Therapeutic apheresis in hematological and oncological diseases. Journal of Clinical Apheresis. 15(1-2). 28–52. 49 indexed citations

12.

Lerner, Raissa, et al.. (2000). Evaluation of Solvent/Detergent‐Treated Plasma in Patients with a Prolonged Prothrombin Time. Vox Sanguinis. 79(3). 161–167. 30 indexed citations

13.

Walpole, Euan, Rasim Gucalp, Avi I. Einzig, et al.. (1993). Survival After Phase II Treatment of Advanced Renal Cell Carcinoma with Taxol or High-Dose Interleukin-2. Journal of Immunotherapy. 13(4). 275–281. 20 indexed citations

14.

Sparano, Joseph A., Janice P. Dutcher, Ronald Kaleya, et al.. (1991). Colonic ischemia complicating immunotherapy with interleukin-2 and interferon-alpha. Cancer. 68(7). 1538–1544. 33 indexed citations

15.

Gaynor, Ellen R., Geoffrey R. Weiss, Kim Margolin, et al.. (1990). Phase I Study of High-Dose Continuous-Infusion Recombinant Interleukin-2 and Autologous Lymphokine-Activated Killer Cells in Patients With Metastatic or Unresectable Malignant Melanoma and Renal Cell Carcinoma. JNCI Journal of the National Cancer Institute. 82(17). 1397–1402. 34 indexed citations

16.

Ehmann, Claudia, et al.. (1988). GPIIIa-related PLA1 antigens with different molecular weights: studies in platelets, endothelial cells, and megakaryocytes. Blood. 71(4). 1056–1061. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact